-43%

est. 2Y upside i

HealthcareSeries A

A self-help app for people to manage their ADHD.

Rank

#4054

Sector

Digital Health / Mental Health

Est. Liquidity

~5Y

Data Quality

Data: Low

This offer carries very high equity risk and should be evaluated almost entirely on cash compensation.

Last updated: May 14, 2026

Bull (12%)+25%

Cerebral successfully integrates Inflow's $12.2M ARR CBT platform, uses it to differentiate its telehealth offering, and achieves a strategic exit or IPO within 4-5 years; Inflow technology becomes a core clinical asset and new hires see roughly 25% appreciation on their Cerebral equity grants. This requires Cerebral to resolve its regulatory overhang and resume meaningful growth — a high bar given recent history.

Base (55%)-35%

Post-acquisition integration is slow and disruptive; Inflow operates as an underfunded subsidiary with murky equity mechanics for new hires, while Cerebral's regulatory and financial challenges suppress valuation. No liquidity event materializes within the 2-year window and equity grants lose roughly 35% of their grant-date value in real terms.

Bear (33%)-80%

Cerebral's continued DEA/regulatory exposure and cash constraints lead to Inflow being deprioritized, restructured, or wound down; the $12.2M ARR base erodes as key talent exits post-acquisition. Employee equity in Cerebral or the Inflow subsidiary becomes effectively worthless within 2 years.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

42%

With $16.7M in total funding and an estimated acquisition price of $30-50M, preferred shareholders absorb 33-56% of all exit proceeds before any common stock (employee equity) participates.

Dilution Risk

high

Three external funding rounds plus the Cerebral acquisition have heavily diluted the original employee pool; new grants sit in Cerebral's larger and more complex cap table with unknown additional preference layers.

Secondary Liquidity

none

Cerebral is private with no known active secondary market, and Inflow had no secondary trading history as a standalone company prior to acquisition.

Questions to Ask at the Interview

Strategic questions based on Inflow's data — designed to show you've done your homework.

  • 1

    “What is the specific legal structure of the Cerebral acquisition — asset purchase, stock deal, or merger — and exactly what equity instrument will new Inflow hires receive: Cerebral options, Inflow subsidiary units, or cash-settled phantom equity?”

  • 2

    “What are Inflow's standalone revenue run-rate and retention metrics today (May 2026) versus the $12.2M ARR reported in December 2023, and is Inflow being operated as an independent P&L or fully absorbed into Cerebral?”

  • 3

    “Has Cerebral resolved its DEA compliance issues and secured sufficient runway (how many months of cash), and what does the Cerebral capitalization table and full liquidation preference stack look like for new equity grantees?”

Community

Valuation Sentiment

Our model estimates -43% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.